Antibiotic Selection for Orchitis in Older Adults

Age-Based Pathogen Considerations

In men over 35 years old, enteric gram-negative bacteria (Enterobacterales such as E. coli) are the predominant pathogens causing epididymo-orchitis, requiring fluoroquinolone coverage rather than agents targeting sexually transmitted infections 1
The European Urology Association recommends considering the patient's age as the critical determinant of antibiotic selection for orchitis, with enteric gram-negative bacteria being more common in older adults 1

The European Urology Association recommends levofloxacin 500 mg orally once daily for 10-14 days as a first-line agent for older adults with orchitis, providing excellent coverage against Enterobacterales and having good tissue penetration 1, 2
Ofloxacin 300-400 mg orally twice daily for 10-14 days is an alternative fluoroquinolone option with similar efficacy, as recommended by the European Urology Association 1, 2
A 10-14 day duration of antibiotic therapy is necessary for adequate treatment of epididymo-orchitis in older adults, according to the European Urology Association 1

The European Urology Association recommends maintaining high clinical suspicion for severe deep tissue infection in high-risk patients, such as those with fever, severe pain, extensive scrotal erythema, or systemic symptoms, which may indicate potential Fournier's gangrene 1, 2, 3
Fournier's gangrene occurs more frequently in diabetic and obese patients, making careful examination essential, as noted by the European Urology Association 1
If Fournier's gangrene is suspected, the European Urology Association recommends immediately initiating broad-spectrum IV antibiotics covering gram-positive cocci, gram-negative organisms, and anaerobes, with urgent surgical consultation 1

Trimethoprim-sulfamethoxazole can provide coverage against common urinary pathogens, though data for orchitis specifically are limited, according to the European Urology Association 1
The European Urology Association recommends avoiding doxycycline monotherapy in patients over 35 years, as it does not adequately cover enteric organisms that predominate in this age group 2

Clinical improvement should occur within 48-72 hours; lack of response warrants imaging to evaluate for abscess formation or alternative diagnoses, as recommended by the European Urology Association 1